Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).
Díez-Pérez A, Adachi JD, Adami S, Anderson FA Jr, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Wyman A, Rushton-Smith SK, Watts NB; Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators.
Díez-Pérez A, et al. Among authors: greenspan sl.
J Bone Miner Res. 2014 Jan;29(1):260-7. doi: 10.1002/jbmr.2023.
J Bone Miner Res. 2014.
PMID: 23794198
Free PMC article.